Education
About Us
Working with TipRanks
Follow Us
Percheron Therapeutics (AU:PER)
ASX:PER
See the Price Targets and Ratings of:
PER Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Wilsons
AU$0.27→AU$0.25
Buy
2400.00%
Upside
Reiterated
11/08/24
Wilsons Remains a Buy on Percheron Therapeutics (PERCF)
Morgans
AU$0.24
Buy
2300.00%
Upside
Reiterated
09/02/24
Morgans Sticks to Its Buy Rating for Antisense Therapeutics Limited (ATHJF)
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wilsons
AU$0.27→AU$0.25
Buy
2400.00%
Upside
Reiterated
11/08/24
Wilsons Remains a Buy on Percheron Therapeutics (PERCF)
Morgans
AU$0.24
Buy
2300.00%
Upside
Reiterated
09/02/24
Morgans Sticks to Its Buy Rating for Antisense Therapeutics Limited (ATHJF)
PER Analyst Recommendation Trends
Rating
Apr 24
May 24
Sep 24
Oct 24
Nov 24
Strong Buy
3
3
3
3
3
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
Each month's total comprises the sum of three months' worth of ratings.
PER Stock Forecast FAQ
What is AU:PER’s average 12-month price target, according to analysts?
Based on analyst ratings, Percheron Therapeutics’s 12-month average price target is AU$0.02.
What is AU:PER’s upside potential, based on the analysts’ average price target?
Percheron Therapeutics has 57.91% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Percheron Therapeutics a Buy, Sell or Hold?
Percheron Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Percheron Therapeutics’s share price target?
The average share price target for Percheron Therapeutics is AU$0.02. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is AU$0.01 ,and the lowest forecast is AU$0.01. The average share price target represents 57.91% Increase from the current price of <AU$0.1.
The highest analyst share price target is AU$0.01 ,and the lowest forecast is AU$0.01. The average share price target represents 57.91% Increase from the current price of <AU$0.1.
What do analysts say about Percheron Therapeutics?
Percheron Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Percheron Therapeutics?
To buy shares of AU:PER, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.